Добавил:
kiopkiopkiop18@yandex.ru t.me/Prokururor I Вовсе не секретарь, но почту проверяю Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз: Предмет: Файл:

Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_4399_Библиотеки_им_академика_М_И_Перельмана

.pdf
Скачиваний:
0
Добавлен:
30.08.2026
Размер:
76 Мб
Скачать
Temporal Bone Histology and Radiology Atlas16
https://t.me/med1917
Figure 2–6. (continued )
first appear, and points 4, 5, and 6 are the sections in which the turns disappear. The slide containing the heli­cotrema is point 7. The slide containing the beginning and end of the hook region (basal-most portion of the cochlea, including up to the round window) is point 8. Two measurements are needed from the slide identified for point 8. Measurement AB represents the distance in millimeters between the inner/outer pillar cells in the basal turn to the inner/outer pillar cells in the proximal hook. Measurement BC represents the distance in mil­limeters between the inner/outer pillar cells in the api­cal portion of the hook and the inner/outer pillar cells in the basal portion of the hook region. Using the eight points, and two measurements, a two-dimensional spi­ral diagram of the cochlea can be drawn on graph paper or plotted using a computer program. If graph paper is used, each box represents 0.2 mm.
A two-dimensional diagram of Rosenthal’s ca-
nal and the spiral ganglion may be constructed in an
analogous manner to that for the cochlear duct recon­struction. Rosenthal’s canal, which contains the spiral ganglion neurons, forms a 1½ turn spiral, whereas the cochlear reconstruction is a 2½ to 3 turn spiral. First, the slides that contain spiral ganglion neurons are identified, and, if using graph paper, these slide num­bers should be used to label the y-axis. Rosenthal’s ca­nal commonly begins at approximately section 200 and ends at approximately section 390. Five key points are needed. Points 1 and 2 are the sections in which spiral ganglion neurons first appear in the modiolus adjacent to the basal and middle turns, respectively. Points 3 and 4 are the sections in which the last spiral ganglion neurons are seen in the basal and middle turns, as sec­tions are viewed from superior to inferior. Point 5 is the most basalward (or superior) section in which spiral ganglion neurons are seen in the hook region. Rosen­thal’s canal is typically divided into Segments I, II, III, and IV based on a vertical midline (Figure 2–7).
Figure 2–7. Two-dimensional reconstruction of Rosenthal’s canal based on identication of slides that contain spiral gan-
https://t.me/med1917
glion neurons (indicated by numbers 1 to 5). The location and number of spiral ganglion neurons can be plotted on this two­dimensional reconstruction.
17
Temporal Bone Histology and Radiology Atlas18
https://t.me/med1917
QUANTIFICATION OF AUDITORY HAIR CELLS
AND SPIRAL GANGLION NEURONS
After creating a two-dimensional reconstruction, in­ner and outer hair cells may be easily quantified by marking their presence or absence on the graph in the basal, middle, and/or apical turns for each slide sec­tion through the cochlea. Hair cells may be identified by their location within the Organ of Corti, presence of stereocilia which is frequently visible at the light microscopic level, and oblong cell shape with round nucleus. Both premortem degeneration of hair cells or postmortem artifact can make identification challeng­ing and there is some subjectivity to determining the presence or absence of a cell in some specimens.
Spiral ganglion neurons are traditionally quanti­fied by the Abercrombie method of utilizing a correction factor to account for the “double counting” that may oc­cur when a structure straddles two sections. Spiral gan­glion neurons may be counted by the number of nuclei or nucleoli. Theoretically, a count based on the number of nucleoli may be more accurate as the nucleolus is smaller than the nucleus. Counting a smaller object ne­cessitates less correction of the actual count because the structure is less likely to straddle two sections (i.e., be double counted); the corrected count is therefore more similar to the empirical count, which should minimize error. Postmortem degeneration or premortem pathol­ogy, however, may result in a pyknotic nucleus, in which identification of the nucleolus is not possible. In addition, given the small size of the nucleolus, counting the number of nucleoli must be done at a magnification of at least 400×, which makes the quantification process more time-consuming. Therefore, due to practical con­straints, quantification of spiral ganglion neurons is of­ten based on counts of the spiral ganglion nuclei.
As noted previously, typically every 10th histo­logic section is mounted on a slide, stained, and avail­able for review in the histologic slide set. To quantify the number of spiral ganglion neurons, every 10th sec­tion through the modiolus is reviewed, and the num­ber of spiral ganglion neuron nuclei or nucleoli are counted. The count is multiplied by 10 to account for intervening sections. This number, which represents the actual count, is then multiplied by a correction factor. The Konigsmark correction factor the diameter of the structure (nucleus or nucleolus) counted and the section thickness, as follows:
correction factor = section thickness /
(section thickness + diameter
of the structure counted).
10
is based on
The average diameter of the spiral ganglion neuron nucleolus is 2 µm, and the typical section thickness is 20 µm. The correction factor for counts based on the nucleolus is 0.91.
11
Nadol verified the accuracy of the Konigsmark correction factor in 1988 by comparing em­pirical counts of spiral ganglion cells to spiral ganglion nucleoli in a human specimen sectioned at a thickness of 2 µm. nucleus is 0.68.
10,11
The correction factor for counts based on the
12
An audio-cytocochleogram provides a graphical summary of remaining cellular structures within the cochlea (Figure 2–8). The audiogram is combined with a graph of the quantified cellular structures, which are plotted along a linear representation of the cochlea that describes both frequency and location. This frequency­location map for the human is based on temporal bone specimens from patients who had abrupt hearing losses over a defined frequency range so that the location of the correlative pathologic findings could be mapped to the frequency.13
Alternatively, a three-dimensional reconstruction of the modiolus provides a very accurate quantifica­tion of spiral ganglion neurons, and avoids estimations and correction factors needed with two-dimensional reconstructions and quantification. However, three­dimensional reconstruction is extremely time-intensive and requires photographing each section and a special­ized computer program. It is therefore not practical for most applications or scientific inquiries requiring quantification of the spiral ganglion neurons in multi­ple specimens. Optical methods of spiral ganglion neu­ron quantification have been successfully performed in guinea pig temporal bones.14 The application of ste­reology to human archival temporal bones for spiral ganglion neuron quantification has suggested that the traditional methods of two-dimensional counting with applied corrections factors may underestimate counts.15
The method of spiral ganglion neuron quantifica­tion based on two-dimensional reconstruction (as de­scribed here) has been applied in many animal and human temporal bone studies. One notable application was the classic study by Schuknecht describing four basic types of presbycusis in humans.16 He quantified hair cells and spiral ganglion neurons by these meth­ods, compared the pathology to audiometric findings in these patients, and identified the typical audiologic features associated with predominant degeneration of the hair cell, spiral ganglion neuron, and stria vascu­laris. Another important use for these methods has been in investigations of the relationship between cochlear implant performance and spiral ganglion neuron cell counts. A recent study demonstrated that, in patients with bilateral cochlear implants who had donated
Figure 2–8. Audiocytocochleogram. This right temporal bone specimen came from a 96-year-old man who had progressive
https://t.me/med1917
sensorineural hearing loss. The audiogram demonstrates a sharply downsloping mild to profound sensorineural hearing loss. The cytocochleogram demonstrates partial loss of inner and outer hair cells in the apical and middle turns, with complete loss of hair cells in the basal turn. There is variable partial loss of stria vascularis. Signicant loss of spiral ganglion neurons throughout the cochlea is shown. The profound high-frequency hearing loss corresponds on the frequency–location map to the complete loss of hair cells in the basal turn. The reduced word recognition score may be explained by both hair cell and spiral ganglion neuron loss.
19
Temporal Bone Histology and Radiology Atlas20
https://t.me/med1917
their temporal bones, the ear with the higher number of spiral ganglion neurons was associated with better cochlear implant performance.12 This affirms that pres­ervation and maintenance of the spiral ganglion neuron population in cochlear implant patients is important; furthermore, it supports the merit of research directed toward maximizing spiral ganglion neuron survival, such as with electrical stimulation and/or neurotrophic support.
QUANTIFICATION OF VESTIBULAR HAIR CELLS
AND SCARPA’S GANGLION NEURONS
Gross vestibular hair cell loss (i.e., more than about 25%) may be assessed using standard light microscopy, but more specific quantification of hair cells requires differential interference contrast (DIC) microscopy.17 Using DIC microscopy with magnification to 100×, type I and type II vestibular hair cells can be reliably distinguished from each other and the surrounding sustentacular cells.18 Type I vestibular neurons have a flask shape and a surrounding nerve chalice and type II vestibular neurons have a cylindrical shape without the surrounding chalice. The neurons can be distinguished from the supporting cells by the stereocilia, which are easily seen in well-preserved specimens using DIC mi­croscopy. Similar to auditory hair cell quantification, vestibular hair cells are counted on every 10th section through the vestibular end organs (semicircular canals, utricle, and saccule), and a correction factor is applied. The vestibular hair cell count is reported as a density (i.e., number of cells per 0.01 mm2), and losses relative to normative data may be determined.19
When the vestibular nerve is intact and preserved as part of the temporal bone specimen, vestibular neu­rons may be quantified by reviewing all stained sec­tions from superior to inferior through the internal au­ditory canal. Vestibular neurons containing a nucleolus are counted, and a correction factor of 0.88 is applied.17 The percent loss compared to normal vestibular neuron population for age may be determined from normative data.20
IMMUNOSTAINING
Immunostaining of human archival temporal bone specimens has progressed significantly in the past de­cade, and has proven to be very successful for some
antigens while challenging for others. Immunohis­tochemistry can detect the presence and location of proteins in tissue sections, and has the potential to sig­nificantly contribute to our understanding of patho­physiology in otologic disorders through its applica­tion to human temporal bone specimens. Some of the challenges in immunostaining in archival temporal bone specimens include postmortem degeneration, re­moval of the embedment material, and variability in the concentration of antibody needed. Robust immu­nostains, such as anti-neurofilament (Figure 2–9), of­ten result in good immunostaining of specimens with more than 24 hours postmortem time prior to fixation, while other immunostains yield more variable results based on the postmortem time.
Since celloidin embedment is advantageous for inner ear morphology preservation, temporal bone specimens are routinely embedded in celloidin. A pro­cess for successful removal of celloidin in preparation for immunostaining has been developed. col for immunostaining for each new antibody must be somewhat empirically derived, and so new immu­nostains are first tried on mouse temporal bone speci­mens that have been histologically processed and em­bedded by the same technique as the human archival specimens. In addition, variations in the fixative and decalcification process affect whether an immunostain is ultimately successful in the human temporal bone specimens. The addition of acetic acid to formalde­hyde fixative, for example, has been found to improve immunostaining results in the cochlea.22 New temporal bone specimens processed in our laboratory are there­fore initially fixed in formaldehyde with acetic acid to optimize future immunostaining results.
Positive immunostaining for macrophages, B-cell lymphocytes, and T-cell lymphocytes with anti-CD68, anti-CD20, and anti-CD3 antibodies was demonstrated surrounding the electrode within the cochlea, consis­tent with a cellular immune response.23 A new class of resident macrophages/microglia was recently found throughout the human temporal bone, including within the spiral ganglion/modiolus, endochondral bone sur­rounding the cochlea, spiral limbus, Organ of Corti, and spiral ligament. Immunostaining for known markers of macrophages and microglia (anti-CD163, anti-IBa1, and anti-CD68) led to the discovery of this cell type within the human temporal bone.24 (Figure 2–10) The signifi­cance of these cells is not yet determined. Given the ubiq­uitous distribution throughout the inner ear and their known role in innate immune defense elsewhere, they may play a role in the development of multiple oto­logic diseases.
21
The proto-
2. Special Temporal Bone Histology Techniques for Both Preparation and Analysis 21
https://t.me/med1917
Figure 2–9. High power image of human Organ of Corti from a temporal bone specimen immunostained for neurolament, us­ing anti-neurolament antibody. The nerve terminals at the base of the inner and outer hair cells (arrows) and dendrites (open triangle) are highlighted with this stain (as shown by the dark brown color). Photo credit: Jennifer O’Malley.
CLINICAL CAVEAT: Immunostaining in human temporal bone specimens from patients who un­derwent cochlear implantation during life has been able to characterize the inflammatory cell infiltrate frequently seen in the cochlea after implantation.
detail at the sub-cellular level, and detail on the mor­phologic structure of cells beyond light microscopy. Rapid fixation of the temporal bone within several hours of death is a requisite for electron microscopy. Significant artifact at the ultra-structural level occurs in specimens with a longer postmortem time prior to fixation. For EM, the inner ear is perfused with glutar­aldehyde via the oval and round windows in order to
and then the temporal bones
,
ELECTRON MICROSCOPY
rapidly initiate fixation may be subsequently removed and placed in fixative.25 The cochlea is then sectioned into separate turns, post-
fixed in osmium tetroxide, dehydrated, embedded in Electron microscopy (EM) of rapidly fixed human tem­poral bone specimens can provide exquisite structural
Epon, further sectioned, and stained with toluidine
blue.25
Figure 2–10. A. Immunostaining for ionized calcium binding protein 1 (anti-IBA1), which stains macrophages and microglia,
https://t.me/med1917
in human archival temporal bone tissue demonstrates an abundance of macrophages/microglia in the spiral ganglion of the cochlea. Arrows indicate spiral ganglion neurons. Open arrow heads indicate macrophages/microglia. B. The multiple processes and morphology of these macrophages/microglia can be seen with anti-IBA1 staining as well at high power. Photo credit: Jen­nifer O’Malley.
22
2. Special Temporal Bone Histology Techniques for Both Preparation and Analysis 23
https://t.me/med1917
Figure 2–11. Electron microscopy of the human spiral ganglion neuron demonstrating the difference in morphology between the type I and type II spiral ganglion neurons. Photo credit: Barbara Burgess and Joseph Nadol, Jr, MD.
EM of the human temporal bone has led to the discovery of new anatomic findings, provided in­sight into the pathophysiology of presbycusis, identi­fied the pathologic correlates of several types of syn­dromic hearing loss, and confirmed the validity of an animal model of hearing loss. With light microscopy, the study of neural degeneration is generally limited to the presence or absence of spiral ganglion cell bod­ies within the modiolus. Using EM, individual affer­ent nerve fi bers, nerve terminals, and synapses can be studied, characterized, and the density per hair cell may be determined (Figure 2–11). Reciprocal synapses, in which both afferent and efferent synaptic specializa­tions exist at the same nerve terminal, were first identi-
fied at the basal poles of human outer hair cells using EM in 1981.26 These synapses may enable communica­tion between outer hair cells through a local neural net­work interconnected by type II spiral ganglion nerve fibers, and modulated by the olivocochlear system.27 EM studies of the human cochlea also identified a sig­nificant reduction in the number of afferent spiral gan­glion neu ron fibers and synapses at the outer hair cells in cases of presbycusis with normal hair cell popula­tions, that is, an early primary neuropathy.25 More re­cent work in animal models of age-related hearing loss using immunostains for nerve terminals, presynaptic ribbons, and postsynaptic receptors demonstrated an analogous pattern of degeneration of synapses, and
Temporal Bone Histology and Radiology Atlas24
https://t.me/med1917
furthermore, reported that this synaptic degeneration precedes measurable age-related decrements in hear­ing.28 Although there are known differences in the sen­sorineural elements of the cochlea in humans versus rodents and other mammals, the prior findings from the human temporal bone EM study help confirm the validity of animal models of age-related hearing loss. In Alport’s syndrome, which results in progressive re­nal failure and hearing loss, EM revealed an abnormal separation of the basilar membrane from the basement membrane of cells of the Organ of Corti.29 This ultra­structural pathology is similar to the findings in the kidney, in which the layers of the glomerular basement membrane separate.
DNA EXTRACTION FROM SPECIMENS
There has been remarkable progress in the discovery of genetic mutations causing hearing loss in recent decades, but associated pathologic findings in the human cochlea have been described in only a small number of genetic hearing loss conditions. Furthermore, with the devel­opment of genome-wide screening tools, extraction of genetic material from the temporal bone spec imens, in which pathology can be determined and au diologic findings can be correlated, would be particularly useful. Unfortunately, efforts to extract DNA from human ar­chival temporal bone specimens have been largely un­successful, in part due to cross-contamination of DNA from the storage of specimens together. RNA extrac­tion is not possible due to the postmortem time prior to tissue procurement, which typically exceeds multiple hours. In recent years, registered temporal bone donors have been asked to donate a buccal swab, which has been stored for later use in DNA analysis. Of note, there are multiple temporal bone specimens from patients in which genetic mutations causing hearing loss were diagnosed during life. This does allow correlation of pathologic findings with genetic findings.
CONCLUSION
Human temporal bone specimens remain a relevant and important source for the continued discovery of pathophysiologic mechanisms of hearing loss. The tra­ditional method for two-dimensional reconstruction of the cochlea and Rosenthal’s canal is used for mapping pathology along the length of the cochlea, and assists
in quantification of hair cell or neuronal losses. Com­puted tomography imaging of specimens yields the ability to definitively correlate radiologic and histo­logic findings in the same specimen, and has been par­ticularly useful in otosclerosis and in determining in­tracochlear electrode position. Immunohistochemistry on archival human temporal bones has been successful with multiple immunostains thus far, and has enabled characterization of the cellular immune response sur­rounding a cochlear implant electrode and discovery of resident macrophages/microglia within the inner ear. EM of rapidly fixed human temporal bone speci­mens can produce high-quality images with excellent ultrastructural detail, and may be used to confirm the validity of animal models or identify new anatomical structures or pathology at the sub-cellular level.
ACKNOWLEDGMENTS
The authors acknowledge the contributions from mem­bers of the Massachusetts Eye and Ear Otopathology Laboratory, particularly Dr. Joseph Nadol, Jr, Jennifer O’Malley, Barbara Burgess, Diane Jones, Meng Yu Zhu, Dr. Joseph Adams, and the late Dr. Saumil Merchant. We also thank Garyfallia Pagonis for her assistance in preparing the figures.
REFERENCES
1. O’Malley JT, Burgess BJ, Zhu MY, Curtin HD, Nadol JB Jr. Correlation between histologic and radiographic recon­struction of intracochlear electrode position in human temporal bones. Audiol Neurootol. 2014;19(3):184–192.
2. O’Malley J, Mitchell R, Jones D, Burgess B, Curtin HD, Merchant SN. The utility of CT scanning prior to process­ing human temporal bones in celloidin. Abstracts of the 32nd
Midwinter Research Meeting of the Association for Research in Otolaryngology. Baltimore, MD. February 14–19, 2009.
3. Quesnel AM, Moonis G, Appel J, O’Malley JT, McKenna MJ, Curtin HD, Merchant SN. Correlation of computed to­mography with histopathology in otosclerosis. Otol Neu- rotol. 2013;34(1):22–28.
4. Kwok OT, Nadol JB Jr. Correlation of otosclerotic foci and degenerative changes in the organ of Corti and spiral gan­glion. J Otolaryngol. 1989;10(1):1–12.
5. Parahy C, Linthicum FH Jr. Otosclerosis and otospongio­sis: clinical and histological comparisons. Laryngoscope. 1984;94(4):508–512.
2. Special Temporal Bone Histology Techniques for Both Preparation and Analysis 25
https://t.me/med1917
6. Quesnel AM, Seton M, Merchant SN, Halpin C, Mc­Kenna MJ. Third-generation bisphosphonates for treat­ment of sensorineural hearing loss in otosclerosis. Otol Neurotol. 2012;33(8):1308–1314.
7. De Oliveira Vicente A, Chandrasekhar SS, Yamashita HK, Cruz OL, Barros FA, Penido NO. Magnetic resonance im­aging in the evaluation of clinical treatment of otospon­giosis: a pilot study. Otolaryngol Head Neck Surg. 2015; 152(6):1119–1126.
8. Guild SR. A graphic reconstruction method for the study of the Organ of Corti, Anat. Rec. 1921;22:141–157.
9. Schuknecht HF. Techniques for study of cochlear func­tion and pathology in experimental animals: develop­ment of anatomical frequency scale of the cat. AMA Arch. Otolaryngol., 1953:58;377–397.
10. Konigsmark BW. Methods for the counting of neurons. In Nanta WJH, Ebbesson SOE, eds. Contemporary Research Methods in Neuro-anatomy. Berlin: Springer-Verlag, 1970: 315–340.
11. Nadol JB Jr. Quantification of human spiral ganglion cells by serial section reconstruction and segmental den­sity estimates. Am J Otolaryngol. 1988;9(2):47–51.
12. Seyyedi M, Viana LM, Nadol JB Jr. Within-subject com­parison of word recognition and spiral ganglion cell count in bilateral cochlear implant recipients. Otol Neu- rotol. 2014 Sep;35(8):1446–1450.
13. Schuknecht HF. Auditory and cytocochlear correlates of inner ear disorders. Otolaryngol Head Neck Surg. 1994; 110(6):530–538.
14. Wrzeszcz A, Reuter G, Nolte I, Lenarz T, Scheper V. Spiral ganglion neuron quantification in the guinea pig cochlea using confocal laser scanning microscopy compared to embedding methods. Hear Res. 2013;306:145–455.
15. Tang Y, Lopez I, Ishiyama A. Application of unbiased ste­reology on archival human temporal bone. Laryngoscope. 2002;112(3):526–533.
16. Schuknecht HF. Presbycusis. Laryngoscope. 1955;65(6): 402–419.
17. Degeneration of Auditory and Vestibular End Organs. In: Merchant SN, Nadol JB Jr, eds. Schuknecht’s Pathology of the Ear, 3rd ed., Shelton, CT: People’s Medical Publish­ing House, 2010.
18. Merchant SN. A method for quantitative assessment of vestibular otopathology. Laryngoscope. 1999;109(10): 1560–1569.
19. Merchant SN, Velázquez-Villaseñor L, Tsuji K, Glynn RJ, Wall C III, Rauch SD. Temporal bone studies of the human peripheral vestibular system. Normative vestibular hair cell data. Ann Otol Rhinol Laryngol Suppl. 2000;181:3–13.
20. Velázquez-Villaseñor L, Merchant SN, Tsuji K, Glynn RJ, Wall C III, Rauch SD. Temporal bone studies of the human peripheral vestibular system. Normative Scarpa’s gan­glion cell data. Ann Otol Rhinol Laryngol Suppl. 2000;181: 14–19.
21. O’Malley JT, Burgess BJ, Jones DD, Adams JC, Merchant SN. Techniques of celloidin removal from temporal bone sections. Ann Otol Rhinol Laryngol. 2009 Jun;118(6):435–441.
22. O’Malley JT, Merchant SN, Burgess BJ, Jones DD, Ad­ams JC. Effects of fixative and embedding medium on morphology and immunostaining of the cochlea. Audiol Neurootol. 2009;14(2):78–87
23. Nadol JB Jr, O’Malley JT, Burgess BJ, Galler D. Cellular immunologic responses to cochlear implantation in the human. Hear Res. 2014;318:11–17.
24. O’Malley JT, Nadol JB Jr, McKenna MJ. Anti CD163+, Iba1+, and CD68+ cells in the adult human inner ear: Normal distribution of an unappreciated class of mac­rophages/microglia and implications for inflammatory otopathology in humans. Otol Neurotol. 2016;37(1):99–108.
25. Nadol JB Jr. Electron microscopic findings in presbycu­sic degeneration of the basal turn of the human cochlea. Otolaryngol Head Neck Surg. 1979;87(6):818–836.
26. Nadol JB Jr. Reciprocal synapses at the base of outer hair cells in the organ of corti of man. Ann Otol Rhinol Laryn- gol. 1981;90(1 Pt 1):12–17.
27. Thiers FA, Nadol JB Jr, Liberman MC. Reciprocal syn­apses between outer hair cells and their afferent termi­nals: evidence for a local neural network in the mamma­lian cochlea. J Assoc Res Otolaryngol. 2008;9(4):477–489.
28. Sergeyenko Y, Lall K, Liberman MC, Kujawa SG. Age­related cochlear synaptopathy: an early-onset contributor to auditory functional decline. J Neurosci. 2013 21;33(34): 13686–13694.
29. Merchant SN, Burgess BJ, Adams JC, Kashtan CE, Greg­ory MC, Santi PA, Colvin R, Collins B, Nadol JB Jr. Tem­poral bone histopathology in alport syndrome. Laryngo- scope. 2004;114(9):1609–1618.